Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ SiteOne Landscape (SITE) Beats Q3 Earnings and Revenue Estimates (Zacks) +++ SITEONE Aktie +3,26%

GE HEALTHCARE Aktie

 >GE HEALTHCARE Aktienkurs 
68.34 EUR    -0.2%    (Tradegate)
Ask: 69.54 EUR / 80 Stück
Bid: 68.4 EUR / 90 Stück
Tagesumsatz: 1337 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
GE HEALTH Aktie über LYNX handeln
>GE HEALTHCARE Performance
1 Woche: +3,8%
1 Monat: +10,2%
3 Monate: +1,2%
6 Monate: +14,5%
1 Jahr: -13,9%
laufendes Jahr: -10,1%
>GE HEALTHCARE Aktie
Name:  GE HEALTHCARE TECHNOLOGIES INC.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US36266G1076 / A3D3G6
Symbol/ Ticker:  L0T (Frankfurt) / GEHC (NASDAQ)
Kürzel:  FRA:L0T, ETR:L0T, L0T:GR, NASDAQ:GEHC
Index:  S&P500
Webseite:  https://www.gehealthcare...
Profil:  GE Healthcare Technology is a leading global medic..
>Volltext..
Marktkapitalisierung:  30704.48 Mio. EUR
Unternehmenswert:  36808.61 Mio. EUR
Umsatz:  17137.76 Mio. EUR
EBITDA:  2981.9 Mio. EUR
Nettogewinn:  1924.41 Mio. EUR
Gewinn je Aktie:  4.21 EUR
Schulden:  9198.05 Mio. EUR
Liquide Mittel:  3229.96 Mio. EUR
Operativer Cashflow:  1712.4 Mio. EUR
Bargeldquote:  0.39
Umsatzwachstum:  -6.98%
Gewinnwachstum:  29.03%
Dividende je Aktie:  0.09 EUR
Dividendenrendite:  0.17%
Dividendenschätzung:  0.18%
Div. Historie:  25.07.25 - 0.03003€
25.04.25 - 0.03003€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  GE HEALTHCARE, GE HEALTH
Letzte Datenerhebung:  29.10.25
>GE HEALTH Kennzahlen
Aktien/ Unternehmen:
Aktien: 456.56 Mio. St.
Frei handelbar: 99.73%
Rückkaufquote: 0.13%
Mitarbeiter: 53000
Umsatz/Mitarb.: 0.32 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 12.57%
Bewertung:
KGV: 16.27
KGV lG: 17.38
KUV: 1.72
KBV: 3.74
PEG-Ratio: 0.37
EV/EBITDA: 12.34
Rentabilität:
Bruttomarge: 40.91%
Gewinnmarge: 11.23%
Operative Marge: 14.56%
Managementeffizenz:
Gesamtkaprendite: 6.66%
Eigenkaprendite: 25.6%
>GE HEALTH Peer Group

Es sind 596 Aktien bekannt.
 
29.10.25 - 13:02
US-Zölle belasten Medizintechnikkonzern GE Healthcare - Trotzdem optimistischer (DPA-AFX)
 
CHICAGO (dpa-AFX) - Dem US-Medizintechnikanbieter GE Healthcare (GE HealthCare Technologies) hat die US-Zollpolitik im dritten Quartal einen Gewinnrückgang eingebrockt. Der Überschuss sank um rund ......
29.10.25 - 12:36
GE HealthCare Tech Profit Slides as Tariffs Drag (WSJ EN)
 
GE HealthCare Technologies' said profit fell in the third quarter, weighed down by the added costs of tariffs....
29.10.25 - 12:24
GE HealthCare Q3 Profit Down, Beats Street; Lifts Low-end Of FY25 Adj. EPS View, Backs Revenue View (AFX)
 
WASHINGTON (dpa-AFX) - GE HealthCare Technologies Inc. (GEHC), while reporting weak third-quarter profit but above the market estimates, on Wednesday raised the lower end of fiscal 2025 adjusted e......
29.10.25 - 11:54
GE HealthCare Technologies Inc. Q3 Profit Decreases, But Beats Estimates (AFX)
 
WASHINGTON (dpa-AFX) - GE HealthCare Technologies Inc. (GEHC) released a profit for third quarter that Decreased from last year but beat the Street estimates.The company's earnings totaled $446 mi......
29.10.25 - 11:46
GE HealthCare reports in line Q3 results, lifts profit outlook; shares down (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
29.10.25 - 11:24
GE HealthCare Technologies Non-GAAP EPS of $1.07 beats by $0.02, revenue of $5.14B beats by $60M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
29.10.25 - 11:21
GE HealthCare reports third quarter 2025 financial results (Business Wire)
 
Revenue growth was 6% and Organic revenue growth* was 4% year-over year, driven by Europe, the Middle East and Africa (EMEA) and the U.S. Organic orders growth was 6% with growth across all segments Net income margin was 8.7%; Adjusted earnings before interest and taxes (EBIT) margin* was 14.8% Diluted earnings per share (EPS) were $0.98; Adjusted EPS* was $1.07 Cash flow from operating activities was $593 million; Free cash flow* was $483 million Excluding tariff impacts, margin and EPS would have exceeded prior year Raises the lower end of full-year 2025 Adjusted EPS* guidance range and reaffirms all other metrics CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2025. GE HealthCare President and CEO Peter Arduini said, “We delivered robust orders with growth across all segments in the third quarter. This was led by customer demand for our differentiated solutions and a healthy capital equipment environment. Revenue perfor...
28.10.25 - 15:33
GE HealthCare Technologies Q3 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
27.10.25 - 15:45
Does GEHC Stock Deserve a Spot in Your Portfolio Ahead of Q3 Earnings? (Zacks)
 
GE HealthCare's Q3 results are expected to show steady growth from Imaging and Diagnostics, though tariffs may weigh on margins and EPS....
24.10.25 - 01:36
GE Healthcare Technologies: A Solid Investment or a Missed Opportunity? (Fool)
 
Join us as we dissect GE Healthcare Technologies and reveal whether it's a smart investment choice or just another stock to avoid....
22.10.25 - 23:36
XFRA: DIVIDEND/INTEREST INFORMATION - 24.10.2025 - US36266G1076 (XETRA)
 
Das Instrument L0T US36266G1076 GE HEALTHC.TECH.INC. -,01 EQUITY wird cum Dividende/Zinsen gehandelt am 23.10.2025 und ex Dividende/Zinsen am 24.10.2025 The instrument L0T US36266G1076 GE HEALTHC.TECH.INC. -,01 EQUITY has its pre-dividend/interest day on 23.10.2025 and its ex-dividend/interest day on 24.10.2025...
22.10.25 - 21:15
GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring (Zacks)
 
GE HealthCare secures CE mark for Carevance, advancing scalable, cost-effective monitoring across care settings....
16.10.25 - 19:30
SmartAlpha Collaborates with GE HealthCare for Regional Anesthesia AI (PR Newswire)
 
SAN ANTONIO, Oct. 16, 2025 /PRNewswire/ -- SmartAlpha announced its collaboration with GE HealthCare to commercialize Nerveblox™, the company's initial AI solution designed to assist ultrasound-guided regional anesthesia. The technology met with U.S. anesthesiologists for the first time......
15.10.25 - 21:15
GEHC Stock Up Following New Launch to Streamline Perinatal Workflow (Zacks)
 
GE HealthCare unveils CareIntellect for Perinatal, a SaaS tool aimed at improving maternal and fetal care delivery....
10.10.25 - 17:30
GE Healthcare Partners With Erasmus to Advance Precision Cancer Care (Zacks)
 
GEHC's collaboration with Erasmus MC aims to advance precision oncology using next-gen total body PET/CT and AI imaging innovations....
09.10.25 - 09:18
GE HealthCare Technologies Earnings Preview: What to Expect (Barchart)
 
GE HealthCare Technologies is gearing up to announce its third-quarter results later this month, and analysts expect a high single-digit drop in earnings....
06.10.25 - 14:33
MediView Closes $24 Million Series A to Redefine Surgical Navigation and Medical Imaging with Augmented Reality (PR Newswire)
 
MediView secures $24M Series A led by GE HealthCare, Mayo Clinic, and Cleveland Clinic to revolutionize image-guided surgery through augmented reality and AI. AR-powered "X-ray vision" gives clinicians real-time 3D data insights—fusing CT and live ultrasound for unprecedented precision,......
01.10.25 - 14:36
GE HealthCare to announce third quarter 2025 results on October 29, 2025 (Business Wire)
 
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2025 financial results before the market opens on Wednesday, October 29, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will be posted at the same link on the GE HealthCare Investor Relations website. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for...
26.09.25 - 18:57
Fuse Oncology Showcases Live Clinical AI Solutions at ASTRO 2025 (PR Newswire)
 
BOONE, N.C., Sept. 26, 2025 /PRNewswire/ -- Fuse Oncology, a leader in AI-powered oncology workflow solutions, mission is to unify radiation oncology workflows through vendor-agnostic solutions that deliver real-world value. This vision will be on display at ASTRO, where GE HealthCare......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Vor einem Fremden tue nichts Heimliches, denn du weißt nicht, was er davon an den Tag bringt. - Altes Testament: Buch Jesus Sirach
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!